Nik Hirani

Interstitial lung disease guideline

Athol U. Wells, Nik Hirani · Thorax · 2008 · 865 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3

Alison C. MacKinnon, Michael Gibbons, Sarah L. Farnworth et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 521 citations · Full text

Medicine, Pathobiology, Pathology +17

Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

Richard J. Allen, Beatriz Guillén‐Guío, Justin M. Oldham et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 341 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study

Richard J. Allen, Joanne Porte, Rebecca Braybrooke et al. · The Lancet Respiratory Medicine · 2017 · 300 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15